The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
19991518: Capital Z Financial Services Fund II, L.P.; PennCorp Financial Group, Inc.
19991516: Capital Z Financial Services Fund II, L.P.; Universal American Financial Corp.
19991260: Photobition Group plc; Wace Group plc
19991212: Xerox Corporation; Visioneer, Inc.
19991211: Visioneer, Inc.; Xerox Corporation
19991669: Charterhouse Equity Partners III, L.P.; Mathew D. Wolf
19991594: Santa Fe Energy Resources, Inc.; Snyder Oil Corporation
19991575: Minnesota Masonic Home; Charles T. Thompson
19991555: M. Michel Besnier; J. R . Simplot Company
19991545: Jefferson Health System, Inc.; Delaware Valley Medical Center
19991465: Iridium LLC; AT&T Corp.
19991414: BellSouth Corporation; AT&T Corp.
19991413: AT&T Corp.; BellSouth Corporation
9902009 Informal Interpretation
PT-1 Communications, Inc., et al.
19991533: Charles E. Hurwitz; Charles E. Hurwitz
19991487: Jotun AS; The Valspar Corporation
Merck & Co., Inc., and Merck-Medco Managed Care, L.L.C
The complaint, issued with the consent order, alleged that as a result of Merck's 1993 acquisition of Medco, the nation's largest benefits manager, Merck's drugs received favorable treatment through Medco's drug-list formulary made available to medical professionals who prescribe and dispense prescriptions to health plan beneficiaries. The consent order requires Medco, among other things, to maintain an "open formulary" to include drugs approved by an independent Pharmacy and Therapeutics Committee, staffed by physicians and pharmacologists who have no financial interest in Merck.